Home>Topics>Companies>St. Jude Medical

St. Jude Medical STJ

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Boston Scientific Exceeds Our Expectations in the Second Quarter

      Commentary

      Thu, 24 Jul 2014

      ICD, Boston racked up 4% year-over-year ICD growth--the strongest seen in 12 quarters. Although peers St . Jude Medical and Medtronic have both launched leadless pacemakers, Boston still offers the only leadless ICD. While Boston

    2. European regulatory clearance for St . Jude catheter

      Headlines

      Tue, 22 Jul 2014

      St . Jude Medical 's (NYSE: STJ ) Flexibility Ablation Catheter achieves CE Mark clearance in Europe. The product has a flexible tip that reduces complications

    3. UPDATE 2- St . Jude not keen to join inversion deal craze

      Headlines

      Wed, 16 Jul 2014

      July 16 (Reuters) - Heart device maker St . Jude Medical Inc said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not

    4. St . Jude Medical's ( STJ ) CEO Dan Starks on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Wed, 16 Jul 2014

      St . Jude Medical Inc. (NYSE: STJ ) Q2 2014 Results Earnings Conference ..... Presentation Operator Welcome to the St . Jude Medical Second Quarter 2014 Earnings Conference ..... and Chief Executive Officer of St . Jude Medical . Before we begin, let me remind

    5. St Jude Medical's quarterly profit doubles as expenses fall

      Headlines

      Wed, 16 Jul 2014

      July 16 (Reuters) - Heart device maker St . Jude Medical Inc reported a quarterly net profit that more than doubled as expenses fell.

    6. More on St . Jude Q2 earnings. 2014 guidance raised.

      Headlines

      Wed, 16 Jul 2014

      St . Jude Medical (NYSE: STJ ) Q2 results: Total Revenues: $1,448M (+3.2%); ICD: $462M (+1.8%); Pacemakers: $271M (+2.7%); AF

    7. St . Jude Medical beats by $0.02, beats on revenue

      Headlines

      Wed, 16 Jul 2014

      St . Jude Medical (NYSE: STJ ): Q2 EPS of $1.02 beats by $0.02 . Revenue of $1.45B (+3.6% Y/Y) beats by $10M . Press Release Post your comment!

    8. St . Jude Delivers Solid 2Q Results

      Commentary

      Wed, 16 Jul 2014

      St . Jude Medical posted solid second-quarter performance ..... estimate in place. We were heartened to see St . Jude 's sales of implantable cardioverter defibrillators ..... recently declined in the low single digits. St . Jude 's recent acquisition of Cardiomems

    9. St . Jude buys NeuroTherm

      Headlines

      Mon, 14 Jul 2014

      St . Jude Medical ( STJ -0.8% ) enters into a definitive agreement to acquire privately ..... conclude the transaction in late Q3. NeuroTherm will add $10M - 15M to STJ 's top-line sales in 2014. NeuroTherm's technology utilizes radiofrequency

    10. New Morningstar Analyst Report for St Jude Medical Inc

      Stock Reports

      Mon, 7 Jul 2014

      that was acquired by St . Jude in 1996. We think Starks ..... reasonable, and like that St . Jude aims to hit the 60th ..... medical device companies, St . Jude makes regular acquisitions ..... for its acquisitions. St . Jude Medical manufactures cardiovascular

    « Prev12345Next »
    Content Partners